WaveMan · Form 4
Orbimed Capital LLC insider trades
> Search tickers & screens ⌘K
LIVE

Orbimed Capital LLC insider trades

Orbimed Capital LLC has filed 7 Form 4s with the SEC that we hold, for ARS Pharmaceuticals, Inc. (SPRY) (Director), RPTX (Director), Arcutis Biotherapeutics, Inc. (ARQT) (10% owner) and Prelude Therapeutics Inc (PRLD) (Director, 10% owner), among 5 companies in all. Across all of them we count 1 purchase worth $5.0M and 23 sales worth $32.0M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 394,400 shares of ARS Pharmaceuticals, Inc. worth $5.3M, dated 2024-08-21. The first filing on our record is dated 2021-08-25 and the latest 2024-08-28.

ARS Pharmaceuticals, Inc. (SPRY)

Director · 2 filings · 5 purchases and sales
Trade dateCodeSharesValue as filedFiled
2024-08-21S, sale reported on Form 4394,400$5.3M2024-08-23
2024-08-21S, sale reported on Form 413,300$194.3K2024-08-23
2024-08-22S, sale reported on Form 4391,482$5.1M2024-08-23
2024-08-23S, sale reported on Form 469,500$905.6K2024-08-23
2024-08-26S, sale reported on Form 483,695$1.1M2024-08-28

RPTX

Director · 2 filings · 12 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-08-23S, sale reported on Form 46,885$234.5K2021-08-25
2021-08-23S, sale reported on Form 4209$7.1K2021-08-25
2021-08-24S, sale reported on Form 43,920$133.6K2021-08-25
2021-08-24S, sale reported on Form 4119$4.1K2021-08-25
2021-08-25S, sale reported on Form 46,874$236.1K2021-08-25
2021-08-25S, sale reported on Form 4208$7.1K2021-08-25
2021-08-26S, sale reported on Form 44,157$143.5K2021-08-30
2021-08-26S, sale reported on Form 4126$4.3K2021-08-30
2021-08-27S, sale reported on Form 46,884$233.6K2021-08-30
2021-08-27S, sale reported on Form 4209$7.1K2021-08-30
2021-08-30S, sale reported on Form 46,500$220.5K2021-08-30
2021-08-30S, sale reported on Form 4197$6.7K2021-08-30

Arcutis Biotherapeutics, Inc. (ARQT)

10% owner · 1 filing · 6 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-04-06S, sale reported on Form 4162,000$3.4M2022-04-08
2022-04-06S, sale reported on Form 4171,204$3.5M2022-04-08
2022-04-07S, sale reported on Form 4167,800$3.5M2022-04-08
2022-04-07S, sale reported on Form 4177,196$3.7M2022-04-08
2022-04-08S, sale reported on Form 497,200$2.0M2022-04-08
2022-04-08S, sale reported on Form 4102,800$2.1M2022-04-08

Prelude Therapeutics Inc (PRLD)

Director, 10% owner · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2023-05-22P, purchase reported on Form 4869,565$5.0M2023-05-24

SRRA

Director, 10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1157524) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms